Adaptive Biotechnologies (ADPT) Debt to Equity (2016 - 2026)
Adaptive Biotechnologies (ADPT) debt to equity from Dec 31, 2016 to Mar 31, 2026. The current Adaptive Biotechnologies (ADPT) debt to equity is 60.34%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Adaptive Biotechnologies (ADPT)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 59.97% | -8.79% |
| 2024 | 65.75% | +55.19% |
| 2023 | 42.37% | +56.87% |
| 2022 | 27.01% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
Comparison Adaptive Biotechnologies (ADPT) debt to equity with competitors
Adaptive Biotechnologies (ADPT) debt to equity is 60.34%.
| Ticker | Name | Debt to Equity | Upside |
|---|---|---|---|
| CRL | Charles River Laboratories International Inc | 0.23% | -99.62% |
| OPK | Opko Health Inc | 0.29% | -99.51% |
| PRPO | Precipio Inc | 0.49% | -99.18% |
| CSTL | Castle Biosciences Inc | 2.18% | -96.38% |
| NTRA | Natera Inc | 4.53% | -92.50% |
| APDN | Applied Dna Sciences Inc | 4.60% | -92.38% |
| DGX | Quest Diagnostics Inc | 6.83% | -88.68% |
| PRPH | ProPhase Labs Inc | 7.54% | -87.51% |
| BLLN | Billiontoone Inc - Class A | 17.80% | -70.50% |
| IDXX | Idexx Laboratories Inc | 28.91% | -52.09% |
| ICLR | Icon Plc | 31.25% | -48.22% |
| WAT | Waters Corp | 31.75% | -47.39% |
| DHR | Danaher Corp | 34.91% | -42.15% |
| MYGN | Myriad Genetics Inc | 35.66% | -40.91% |
| WGS | GeneDx Holdings Corp - Class A | 38.06% | -36.92% |
| NEO | Neogenomics Inc | 40.86% | -32.28% |
| QGEN | Qiagen NV | 43.79% | -27.43% |
| RVTY | Revvity Inc | 44.66% | -25.99% |
| A | Agilent Technologies Inc | 47.11% | -21.94% |
| LH | Laboratory Corp Of America Holdings | 72.57% | +20.25% |
| TMO | Thermo Fisher Scientific Inc | 88.65% | +46.90% |
| RDNT | Radnet Inc | 100.55% | +66.62% |
| XGN | Exagen Inc | 158.47% | +162.61% |
| IQV | IQVIA Holdings Inc | 254.51% | +321.76% |
| SHC | Sotera Health Company | 343.50% | +469.23% |
| NOTV | Inotiv, Inc. Common Stock | 532.33% | +782.15% |
| BDSX | Biodesix Inc | 547.55% | +807.36% |